High-density lipoprotein functionality in systemic lupus erythematosus.

Seminars in Arthritis and Rheumatism
Shiva GanjaliAmirhossein Sahebkar

Abstract

Systemic lupus erythematosus (SLE) is a heterogeneous disease which is characterized with excessive inflammation and autoantibodies, macrophage and complement activation, and subsequently immunologically mediated tissue damage. In spite of improved treatments of SLE, these patients experience premature atherosclerosis and the rate of mortality among them remains high. Autoantibodies and circulating immune complexes might contribute to the pathogenesis of atherosclerosis by injuring the endothelium, as well as inducing pro-inflammatory and pro-adhesive endothelial cell phenotypes, as well as altering the metabolism of lipoproteins involved in atherogenesis. Hence, high levels of atherogenic lipoproteins (like low-density lipoprotein (LDL) and very low-density lipoprotein (VLDL)) and low levels of high-density lipoprotein (HDL-C) are important risk factors for atherosclerotic cardiovascular complications in SLE patients but these traditional risk factors fail to fully explain the increased risk of cardiovascular disease (CVD) in these patients. The exact mechanism by which inflammation decreases HDL levels is not defined, but decreases in apoA-I production and lecithin cholesterol acyltransferase (LCAT) activity, as well as incre...Continue Reading

References

Sep 1, 1988·The Journal of Clinical Endocrinology and Metabolism·W H Ettinger, W R Hazzard
Sep 1, 1987·The American Journal of Medicine·W H EttingerW R Hazzard
Apr 17, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·M NavabA M Fogelman
May 2, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Albert SalazarRamon Pujol
Dec 11, 2002·Best Practice & Research. Clinical Rheumatology·Michelle Petri
Dec 19, 2003·The New England Journal of Medicine·Bevra Hannahs Hahn
Jul 24, 2007·Clinica Chimica Acta; International Journal of Clinical Chemistry·Hiroe SatoFumitake Gejyo
Sep 26, 2007·Annals of the New York Academy of Sciences·Emese KissGyörgy Paragh
Jan 14, 2009·Translational Research : the Journal of Laboratory and Clinical Medicine·Elisa Y RhewRosalind Ramsey-Goldman
Mar 4, 2009·Critical Reviews in Clinical Laboratory Sciences·Jordi CampsJorge Joven
Jul 30, 2009·Rheumatology International·Rosa Weiss TellesEmilia Inoue Sato
Sep 17, 2009·JAMA : the Journal of the American Medical Association·Marietta CharakidaJohn E Deanfield
Mar 18, 2010·Biochemical and Biophysical Research Communications·Seiichiro AndoYoshinari Takasaki
Apr 7, 2010·Diabetes & Vascular Disease Research : Official Journal of the International Society of Diabetes and Vascular Disease·Rachel G MillerTrevor J Orchard
May 19, 2010·Biomarkers in Medicine·Alexander TorresCharles J Malemud
Apr 30, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Natacha BellangerMaryse Guerin
Aug 16, 2011·Trends in Molecular Medicine·Laurent CamontAnatol Kontush

❮ Previous
Next ❯

Citations

Jun 3, 2021·Biomedicines·Athina Trakaki, Gunther Marsche

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.